Locker GY - Search Results

1

Chemotherapy for murine ovarian cancer: a rationale for ip therapy with adriamycin.

Ozols RF, Locker GY, Doroshow JH, Grotzinger KR, Myers CE, Fisher RI, Young RC. Ozols RF, et al. Among authors: locker gy. Cancer Treat Rep. 1979 Feb;63(2):269-73. Cancer Treat Rep. 1979. PMID: 445504

2

Pharmacokinetics of adriamycin and tissue penetration in murine ovarian cancer.

Ozols RF, Locker GY, Doroshow JH, Grotzinger KR, Myers CE, Young RC. Ozols RF, et al. Among authors: locker gy. Cancer Res. 1979 Aug;39(8):3209-14. Cancer Res. 1979. PMID: 455305 No abstract available.

3

Experimental animal models of adriamycin cardiotoxicity.

Doroshow JH, Locker GY, Myers CE. Doroshow JH, et al. Among authors: locker gy. Cancer Treat Rep. 1979 May;63(5):855-60. Cancer Treat Rep. 1979. PMID: 110445

4

Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine.

Doroshow JH, Locker GY, Ifrim I, Myers CE. Doroshow JH, et al. Among authors: locker gy. J Clin Invest. 1981 Oct;68(4):1053-64. doi: 10.1172/jci110328. J Clin Invest. 1981. PMID: 7287901 Free PMC article.

5

Ocular irritation from high-dose methotrexate therapy: pharmacokinetics of drug in the tear film.

Doroshow JH, Locker GY, Gaasterland DE, Hubbard SP, Young RC, Myers CE. Doroshow JH, et al. Among authors: locker gy. Cancer. 1981 Nov 15;48(10):2158-62. doi: 10.1002/1097-0142(19811115)48:10<2158::aid-cncr2820481007>3.0.co;2-i. Cancer. 1981. PMID: 7296473

6

The clinical features of hepatic angiosarcoma: a report of four cases and a review of the English literature.

Locker GY, Doroshow JH, Zwelling LA, Chabner BA. Locker GY, et al. Medicine (Baltimore). 1979 Jan;58(1):48-64. doi: 10.1097/00005792-197901000-00003. Medicine (Baltimore). 1979. PMID: 368508 Review.

7

The effect of doxorubicin on hepatic and cardiac glutathione.

Doroshow JH, Locker GY, Baldinger J, Myers CE. Doroshow JH, et al. Among authors: locker gy. Res Commun Chem Pathol Pharmacol. 1979 Nov;26(2):285-95. Res Commun Chem Pathol Pharmacol. 1979. PMID: 574979

8

Enzymatic defenses of the mouse heart against reactive oxygen metabolites: alterations produced by doxorubicin.

Doroshow JH, Locker GY, Myers CE. Doroshow JH, et al. Among authors: locker gy. J Clin Invest. 1980 Jan;65(1):128-35. doi: 10.1172/JCI109642. J Clin Invest. 1980. PMID: 7350193 Free PMC article.

9

A randomized controlled trial assessing the prevention of doxorubicin cardiomyopathy by N-acetylcysteine.

Myers C, Bonow R, Palmeri S, Jenkins J, Corden B, Locker G, Doroshow J, Epstein S. Myers C, et al. Semin Oncol. 1983 Mar;10(1 Suppl 1):53-5. Semin Oncol. 1983. PMID: 6340204 Clinical Trial. No abstract available.

10

Antineoplastic drugs: clinical pharmacology and therapeutic use.

Bender RA, Zwelling LA, Doroshow JH, Locker GY, Hande KR, Murinson DS, Cohen M, Myers CE, Chabner BA. Bender RA, et al. Among authors: locker gy. Drugs. 1978 Jul;16(1):46-87. doi: 10.2165/00003495-197816010-00003. Drugs. 1978. PMID: 78795 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters